SCHEMBL19797941

SCHEMBL19797941

Cc1ccc(/C(C#N)=C(\C#N)c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
MAPT P10636 6/20 0.37
PTGES O14684 1/20 0.37
ALOX5 P09917 1/20 0.37
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
CYP2C19 P33261 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 2/20 0.36
APP P05067 1/20 0.36
SLC16A3 O15427 1/20 0.35
SLC16A1 P53985 1/20 0.35
ALDH1A1 P00352 3/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
HPGD P15428 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15494352 0.95 MEN1 (0.40) MEN1KMT2AMAPTCES2CES1
SCHEMBL14029172 0.94 CES2 (0.43) MEN1KMT2AMAPTCES2CES1
SCHEMBL15494366 0.88 ALDH1A1 (0.38) MEN1KMT2AMAPTCES2CES1
SCHEMBL14744144 0.87 MEN1 (0.46) MEN1KMT2AMAPTCYP2C19CYP1A2
SCHEMBL14744143 0.87 MEN1 (0.46) MEN1KMT2AMAPTCYP2C19CYP1A2
SCHEMBL18385889 0.84 SLC22A2 (0.44) MEN1KMT2AMAPTCYP2C19CYP1A2
SCHEMBL5001311 0.83 ALDH1A1 (0.41) MEN1KMT2AMAPTCES2CES1
SCHEMBL5001309 0.83 ALDH1A1 (0.41) MEN1KMT2AMAPTCES2CES1
SCHEMBL15306805 0.81 CES2 (0.54) MEN1KMT2AMAPTCES2CES1
SCHEMBL12593268 0.81 ALDH1A1 (0.50) MEN1KMT2AMAPTCYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11578265-B2 AIEgens for cancer cell imaging THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2023-02-14 US disclosed
US-20210371735-A1 AIEgens for Cancer Cell Imaging THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2021-12-02 US disclosed
WO-2018014865-A1 AIEGENS FOR CANCER CELL IMAGING THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2018-01-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11578265-B2 AIEgens for cancer cell imaging CD4, MKI67, CCNB1 MEN1 308/4885KMT2A 3649/4885MAPT 3185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.